Study to compare drug availability in bloodstream of two oral formulations of mesalazine in healthy volunteers under fed conditions.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517107-37-00

Acronym

CLEU-0524/FED

Enrollment

Registered

2024-11-11

Start date

2024-12-20

Completion date

2025-02-21

Last updated

2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic idiopathic inflammatory bowel disease

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026